{
    "2018-09-28": [
        [
            {
                "time": "",
                "original_text": "长春高新:业绩高增长,生物制药业务超预期",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩高增长",
                        "生物制药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:抵扣新规落地,研发利好加码",
                "features": {
                    "keywords": [
                        "医药生物",
                        "抵扣新规",
                        "研发利好"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}